You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

Citation Tools

Article menu

Download PDFPDF

XML
Paediatrics
Protocol
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lyttle MD, Bielicki JA, Barratt S, et al
Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)
BMJ Open 2019;9:e029875. doi: 10.1136/bmjopen-2019-029875